Led · Series A · Jan 2022

PostEra is a biotechnology company that applies machine learning to accelerate preclinical small-molecule drug discovery. Its platform tightly integrates the Design-Make-Test cycle of medicinal chemistry and has been used across a variety of drug discovery programs. The company cites rapid development of COVID oral antiviral candidates via the COVID Moonshot and the launch of Manifold, an industry synthesis platform, as demonstrations of its approach. PostEra plans to advance a series of partnered drug discovery programs and to initiate internal drug discovery efforts. The company will also further develop its medicinal chemistry platform and announced a multi-target strategic partnership with Pfizer to establish an AI Lab. PostEra closed new equity financing to support these plans.

Led · Equity · Feb 2019

OakNorth is a UK challenger bank and fintech whose product suite includes a 'Credit Intelligence' software for commercial lending. The company sells software intended to enhance banks' commercial-lending propositions and decisioning. Sumitomo Mitsui Banking Corporation (SMBC) has deployed OakNorth’s Credit Intelligence in the US and Asia. SMBC also invested $30 million in OakNorth via a secondary transaction as part of the relationship. OakNorth previously received a £90 million investment from GIC almost three years ago. According to Crunchbase, the company has raised more than $1 billion to date. OakNorth builds a digital bank focused on fast, flexible loans to small and medium enterprises and property developers in the U.K. It uses big data and machine learning to assess credit risk and monitor loan portfolios. The company also licenses its OakNorth Analytical Intelligence platform to other banks for loan origination, credit analysis and portfolio monitoring, with multiple banks using it across the U.S., Europe and Asia. OakNorth has lent more than $3.7 billion overall with no reported defaults or late payments, and it manages 34,000 savings accounts for individuals and businesses. The company plans to double down on its existing business and expand into the U.S. via partnerships and loan origination rather than opening a U.S. bank. Prior to this round it had raised $848 million in primary funding since its creation. Launched in September 2015 by Rishi Khosla and Joel Perlman, OakNorth provides fast, flexible debt finance (typically £500k–£40m) to businesses and established property developers and investors. The bank also offers a range of FSCS-protected savings products for individuals and businesses, including fixed-term, easy-access, notice and cash ISA accounts. OakNorth is authorized by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the PRA; it has a loan book of £1.7bn and raised deposits from about 20,000 savers. The company operates ACORN machine, a cloud-based fintech platform that leverages machine learning to automate credit decisioning and portfolio monitoring and to help banks enter the SME lending market. Clients span nurseries, hotels, care homes, private equity firms, restaurants and well-known property developers and retailers. OakNorth has offices in London, New York and Singapore, employs almost 100 people, and expects to have over $5bn of assets under service on its platform by year end. OakNorth is a London, UK-based bank providing debt finance from £500k to £25m to fast-growth businesses and established property developers. The bank has launched ACORN machine, its fintech platform for lenders worldwide, built on three pillars: data, technology, and process. ACORN collects millions of data items and uses machine learning algorithms to surface the pieces of data lenders need for credit decisions. The technology environment is java- and web-based and cloud-hosted via AWS, combining proprietary and best-of-breed components. Clients include Leon, Galliard Homes, Frogmore, Brasserie Blanc, Strawberry Star and The Collective. OakNorth is authorized by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the PRA and is positioning to expand in the US, European and Asian markets.

Led · Series A · Sep 2016

Halodoc is a Jakarta, Indonesia-based digital healthcare ecosystem platform that delivers an all-in-one application covering preventive to curative services. Led by CEO & co-founder Jonathan Sudharta, the company offers services including Home Lab (at-home health tests) and My Insurance (cashless outpatient access integrated with insurers). Halodoc focuses on health communication, education, and information to raise digital health literacy in Indonesia. The company works with the government to accelerate healthcare technology and telehealth regulation under the Ministry of Health. Halodoc said it will use the funds to expand operations, broaden its business reach, and widen its range of services. Early backers include Acrew Capital, Argor (previously Go-Ventures), Allianz X, Bangkok Bank, the Bill & Melinda Gates Foundation, HEAL Partners, Intudo Ventures and others. Halodoc operates a mobile app and website that enable live consultations with more than 20,000 licensed doctors across Indonesia. The platform launched an appointment service in 2020 that connects over 2,000 providers to patients in more than 180 cities. Its Health Store partners with 4,000+ pharmacies to deliver supplements, prescription drugs and other items; Chat with Doctor supports voice, video and chat interactions; and Appointment covers 1,000+ partner hospitals plus COVID-19 testing and vaccination scheduling. Founded in 2016 and led by CEO Jonathan Sudartha, Halodoc aims to deepen its penetration in key healthcare verticals across Indonesia. The company recently completed a new financing round which it plans to deploy toward expanding services and provider reach. The article does not disclose revenue or user counts beyond the provider and partner metrics noted above. Halodoc is an Indonesian healthtech platform offering online consultations with over 20,000 licensed doctors, prescription delivery, and lab test bookings. Founded in 2016, the standalone app also links with Go-Jek's Go-Med feature and uses Go-Jek drivers for medicine deliveries. The platform has collaborated with more than 1,400 hospitals and health service providers and integrates insurance services for hospital visits. Halodoc reports 2 million monthly active users, over 80% of whom are located outside Java, and its user numbers increased 25-fold in a 12-month period in 2018. The company raised IDR 920 billion (US$65 million) in a Series B led by UOB Venture Management to develop services and expand partnerships with health service and insurance providers. Management says the investment will accelerate development of its digital platform to increase access and convenience for millions of users in Indonesia. HaloDoc is Indonesia's first online healthcare application. The company operates an app-based platform delivering healthcare services in Indonesia. It announced it has secured a $13 million Series A funding round. The Series A was led by Clermont Group, a Singapore-based private investment firm. The article's headline also cites participation from Go-Jek and other unnamed investors. The article does not disclose operating metrics, future plans, or additional financial details.